000 01376 a2200385 4500
005 20250513211307.0
264 0 _c20000830
008 200008s 0 0 eng d
022 _a0264-410X
024 7 _a10.1016/s0264-410x(00)00076-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFuller, T E
245 0 0 _aA genetically-defined riboflavin auxotroph of Actinobacillus pleuropneumoniae as a live attenuated vaccine.
_h[electronic resource]
260 _bVaccine
_cJun 2000
300 _a2867-77 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aActinobacillus Infections
_ximmunology
650 0 4 _aActinobacillus pleuropneumoniae
_xgenetics
650 0 4 _aAnimals
650 0 4 _aBacterial Vaccines
_xadministration & dosage
650 0 4 _aCulture Media
650 0 4 _aInjections, Intramuscular
650 0 4 _aIntubation, Intratracheal
650 0 4 _aMale
650 0 4 _aMutation
650 0 4 _aRiboflavin
_xphysiology
650 0 4 _aSwine
650 0 4 _aSwine Diseases
_ximmunology
650 0 4 _aVaccines, Attenuated
_xadministration & dosage
700 1 _aThacker, B J
700 1 _aDuran, C O
700 1 _aMulks, M H
773 0 _tVaccine
_gvol. 18
_gno. 25
_gp. 2867-77
856 4 0 _uhttps://doi.org/10.1016/s0264-410x(00)00076-1
_zAvailable from publisher's website
999 _c10764068
_d10764068